EHC

SEC source: 0001127602-19-017270 · form4.xml · derivative · entry 7

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Encompass Health Common Stock · 33,331 shares

Expires 2020-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in three equal installments on the anniversaries of the grant date beginning on the date set forth.

SEC source: 0001127602-19-017270 · form4.xml · derivative · entry 6

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Encompass Health Common Stock · 10,550 shares

Expires 2019-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested in three equal installments on the anniversaries of the grant date beginning on the date set forth.

SEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 5

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,377

F2 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.07 to $63.31, exclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

SEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 4

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,320

F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.31 to $64.30, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

SEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 3

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-19-017270 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-19-016102 · form4.xml · nonDerivative · entry 2

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,860

F2 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016102 · form4.xml · nonDerivative · entry 1

SHAW L EDWARD JR · CIK 0001183337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,569

F1 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-19-016101 · form4.xml · nonDerivative · entry 1

SCHLICHTING NANCY M · CIK 0001376358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,351

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016100 · form4.xml · nonDerivative · entry 2

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,353

F2 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016100 · form4.xml · nonDerivative · entry 1

MAUPIN JOHN E JR D D S · CIK 0001189149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,062

F1 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-19-016099 · form4.xml · nonDerivative · entry 1

KATZ LESLYE G · CIK 0001193884 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,916

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016097 · form4.xml · nonDerivative · entry 1

HERMAN JOAN E · CIK 0001248398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,916

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016098 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,575

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016096 · form4.xml · nonDerivative · entry 1

ELSON CHARLES M · CIK 0001122124 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,165

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016095 · form4.xml · nonDerivative · entry 1

CURL YVONNE M · CIK 0001135567 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,142

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016094 · form4.xml · nonDerivative · entry 1

CORRELL DONALD L · CIK 0001199794 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,405

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-016093 · form4.xml · nonDerivative · entry 2

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,228

F2 · shares: Pursuant to Encompass Health Corporation's Directors Deferred Stock Investment Plan (the "Plan"), cash dividends on shares of Encompass Health common stock held under the Plan are reinvested by the Plan administrator. The Plan is a nonqualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections to defer fixed percentages of their directors fees for the following year. The deferred fees fund the purchase of Encompass Health common stock by the Plan administrator in the market for the account of each participating director and such stock is entitled to cash dividends under the Plan. On April 15, 2019, the Company paid a dividend on common stock of $0.27 per share. The transaction reported on this Form 4 is a purchase of shares of common stock of Encompass Health in the market with that dividend payment.

SEC source: 0001127602-19-016093 · form4.xml · nonDerivative · entry 1

CHIDSEY JOHN · CIK 0001128484 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,505

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

SEC source: 0001127602-19-010521 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,284

SEC source: 0001127602-19-009501 · form4.xml · derivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,326

Underlying: Encompass Health Common Stock · 10,326 shares

Expires 2029-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020.

SEC source: 0001127602-19-009466 · form4.xml · derivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,572

Underlying: Encompass Health Common Stock · 57,572 shares

Expires 2029-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020.

SEC source: 0001127602-19-009516 · form4.xml · derivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO & President, Home Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,515

Underlying: Encompass Health Common Stock · 6,515 shares

Expires 2029-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020.

SEC source: 0001127602-19-009510 · form4.xml · derivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,237

Underlying: Encompass Health Common Stock · 14,237 shares

Expires 2029-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020.

SEC source: 0001127602-19-009483 · form4.xml · derivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,522

Underlying: Encompass Health Common Stock · 17,522 shares

Expires 2029-03-01

F1 · derivative.exercise_date: The option becomes exercisable in annual installments over a three-year period, at the rate of 33.3% per year commencing March 1, 2020.

SEC source: 0001127602-19-008426 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,377

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008425 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,526

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008424 · form4.xml · nonDerivative · entry 1

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,732

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008423 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,155

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008420 · form4.xml · nonDerivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,305

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008422 · form4.xml · nonDerivative · entry 1

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,391

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008418 · form4.xml · nonDerivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,475

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-008416 · form4.xml · nonDerivative · entry 1

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,223.726

F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

SEC source: 0001127602-19-007467 · form4.xml · nonDerivative · entry 2

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,702

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007467 · form4.xml · nonDerivative · entry 1

Fay Edmund · CIK 0001433234 · Sr. Vice Pres. and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,401

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007466 · form4.xml · nonDerivative · entry 2

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,352

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007466 · form4.xml · nonDerivative · entry 1

Tarr Mark J · CIK 0001304057 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,256

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007464 · form4.xml · nonDerivative · entry 2

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,840

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007464 · form4.xml · nonDerivative · entry 1

Price Andrew L · CIK 0001475399 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,539

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007463 · form4.xml · nonDerivative · entry 1

Levy Cheryl B. · CIK 0001513212 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,217

F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007462 · form4.xml · nonDerivative · entry 2

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,621

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007462 · form4.xml · nonDerivative · entry 1

Jacobsmeyer Barbara Ann · CIK 0001691132 · President, Inpatient Hospitals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,846

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007461 · form4.xml · nonDerivative · entry 2

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,708

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007461 · form4.xml · nonDerivative · entry 1

Darby John Patrick · CIK 0001664699 · EVP, Gen Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,223

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007460 · form4.xml · nonDerivative · entry 2

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,266

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007460 · form4.xml · nonDerivative · entry 1

COLTHARP DOUGLAS E · CIK 0001186879 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,772

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007459 · form4.xml · nonDerivative · entry 2

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,463.726

F2 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 17, 2017.

SEC source: 0001127602-19-007459 · form4.xml · nonDerivative · entry 1

Charbonneau Elissa Joy · CIK 0001647458 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,404.726

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.

SEC source: 0001127602-19-007458 · form4.xml · nonDerivative · entry 1

Anthony April Kaye Bullock · CIK 0001629441 · CEO and President, Encompass

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,561

F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.